Skip to main content

Table 1 Characteristics of SSP participants inducted onto buprenorphine (N = 115)

From: Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs

  n (%)
Age (in years)
 <30 17 (15%)
 30–39 35 (30%)
 40–49 32 (28%)
 ≥50 31 (27%)
Gender
 Cisgender male 83 (72%)
 Cisgender female 32 (28%)
Time to Induction
 Same Day as Referral 100 (87)
 One Day after Referral 7 (6)
 More than One Day after Referral 8 (7)
Payment method
 Medicaid/Medicare 106 (92%)
 Private 5 (4%)
 Self-pay 4 (4%)
Prescription refill 74 (64%)